Abnormal Uterine Bleeding, Unspecified
7
1
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
14.3%
1 terminated out of 7 trials
50.0%
-36.5% vs benchmark
29%
2 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Assessment of Female Sexual Function Index (FSFI) Scores at 1 Month After Endometrial Sampling Performed Under Sedo-Analgesia or Local Anesthesia
The Learning Curve of a Gynecology and Obstetrics Resident Performing Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) Hysterectomy in a University Hospital
Evaluation of the Uterine Cavity in Perimenopausal Women.
Vaginal vs. Laparoscopic Hysterectomy
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Prophylactic Bilateral Salpingectomy and Laparoscopic Myomectomy